Bernstein Maintains Market Perform on Dyne Therapeutics, Raises Price Target to $24

Dyne Therapeutics Inc

Dyne Therapeutics Inc

DYN

0.00

Bernstein analyst William Pickering maintains Dyne Therapeutics (NASDAQ: DYN) with a Market Perform and raises the price target from $23 to $24.